Search Results - Lothar Roessig

Refine Results
  1. 1
    Soluble GC stimulators and activators: Past, present and future

    Soluble GC stimulators and activators: Past, present and future by Peter Sandner, Markus Follmann, Eva Becker‐Pelster, Michael G. Hahn, Christian Meier, Cecilia Freitas, Lothar Roessig, Johannes‐Peter Stasch

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial

    Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial by Michele Senni, J. López‐Sendón, Alain Cohen‐Solal, Piotr Ponikowski, Richard Nkulikiyinka, Cecilia Freitas, Vanja Vlajnic, Lothar Roessig, Burkert Pieske

    Published 2022
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction

    Evaluation of high‐sensitivity C‐reactive protein and uric acid in vericiguat‐treated patients with heart failure with reduced ejection fraction by Frank Kramer, Sebastian Voß, Lothar Roessig, Bernd‐Wolfgang Igl, Javed Butler, Carolyn S.P. Lam, Aldo P. Maggioni, Sanjiv J. Shah, Burkert Pieske

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction

    Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction by Diana Bonderman, Stefano Ghio, Stephan B. Felix, Hossein Ardeschir Ghofrani, Evangelos D. Michelakis, Veselin Mitrović, Ronald J. Oudiz, Francis Boateng, Andrea‐Viviana Scalise, Lothar Roessig, Marc J. Semigran

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction

    The cGMP Signaling Pathway as a Therapeutic Target in Heart Failure With Preserved Ejection Fraction by Stephen J. Greene, Mihai Gheorghiade, Barry A. Borlaug, Burkert Pieske, Muthiah Vaduganathan, John C. Burnett, Lothar Roessig, Johannes‐Peter Stasch, Scott D. Solomon, Walter J. Paulus, Javed Butler

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials

    Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials by Jacob P. Kelly, Robert J. Mentz, Alexandre Mebazaa, Adriaan A Voors, Javed Butler, Lothar Roessig, Mona Fiuzat, Faı̈ez Zannad, Bertram Pitt, Christopher M. O’Connor, Carolyn S.P. Lam

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)

    Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1) by Diana Bonderman, Ingrid Pretsch, Regina Steringer‐Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, Carolyn S.P. Lam, Reiner Frey, Michael Ochan Kilama, Sigrun Unger, Lothar Roessig, Iréne Lang

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure

    Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failure by Athanasios Frydas, Daniel A. Morris, Evgeny Belyavskiy, Aravind‐Kumar Radhakrishnan, Martin Kropf, Marijana Tadić, Lothar Roessig, Carolyn S.P. Lam, Sanjiv J. Shah, Scott D. Solomon, Burkert Pieske, Elisabeth Pieske‐Kraigher

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study

    Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRES... by Burkert Pieske, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Gerasimos Filippatos, Javed Butler, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Mihai Gheorghiade

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Rationale and design of the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE</scp> Studies (<scp>SOCRATES</scp>)

    Rationale and design of the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE</scp> Studies (<scp>SOCRATES</scp>) by Burkert Pieske, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Andrea Scalise, Katharina Müller, Lothar Roessig, Mihai Gheorghiade

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction

    Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction by Mihai Gheorghiade, Stephen J. Greene, Javed Butler, Gerasimos Filippatos, Carolyn S.P. Lam, Aldo P. Maggioni, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Elisabeth Kraigher‐Krainer, Eliana T. Samano, Katharina Müller, Lothar Roessig, Burkert Pieske

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

    Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial by Carolyn S.P. Lam, Hillary Mulder, Yuri Lopatin, Jose Vazquez-Tanus, D. Siu, Justin A. Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Patient‐reported outcomes in the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE patientS</scp> with <scp>PRESERVED</scp> ejection fraction (<scp>SOCRATES‐PRESERVED</scp>) study

    Patient‐reported outcomes in the <scp>SOluble</scp> guanylate Cyclase <scp>stimulatoR</scp> in <scp>heArT failurE patientS</scp> with <scp>PRESERVED</scp> ejection fraction (<scp>S... by Gerasimos Filippatos, Aldo P. Maggioni, Carolyn S.P. Lam, Elisabeth Pieske‐Kraigher, Javed Butler, John A. Spertus, Piotr Ponikowski, Sanjiv J. Shah, Scott D. Solomon, Andrea‐Viviana Scalise, Katharina Mueller, Lothar Roessig, Luke Bamber, Mihai Gheorghiade, Burkert Pieske

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator

    A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator by Paul W. Armstrong, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Javed Butler, Adriaan A. Voors, Carolyn S.P. Lam, Piotr Ponikowski, Tracy Temple, Burkert Pieske, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Christopher M. O’Connor

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial

    Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial by Burkert Pieske, Mahesh J. Patel, Cynthia M. Westerhout, Kevin J. Anstrom, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Joerg Koglin, Carolyn S.P. Lam, Piotr Ponikowski, Lothar Roessig, Adriaan A. Voors, Christopher M. O’Connor, Paul W. Armstrong

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Heart Failure Clinical Trials in East and Southeast Asia

    Heart Failure Clinical Trials in East and Southeast Asia by Robert J. Mentz, Lothar Roessig, Barry Greenberg, Naoki Sato, Kaori Shinagawa, Daniel Yeo, Bernard W.K. Kwok, Eugenio Reyes, Henry Krum, Burkert Pieske, Stephen J. Greene, Andrew P. Ambrosy, Jacob P. Kelly, Faı̈ez Zannad, Bertram Pitt, Carolyn S.P. Lam

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes

    N-Terminal Pro-B-Type Natriuretic Peptide and Clinical Outcomes by Justin A. Ezekowitz, Christopher M. O’Connor, Richard W. Troughton, Wendimagegn Alemayehu, Cynthia M. Westerhout, Adriaan A. Voors, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Michele Emdin, Mahesh J. Patel, Burkert Pieske, Lothar Roessig, Adrian F. Hernandez, Paul W. Armstrong

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction

    Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction by Paul W. Armstrong, Burkert Pieske, Kevin J. Anstrom, Justin A. Ezekowitz, Adrian F. Hernandez, Javed Butler, Carolyn S.P. Lam, Piotr Ponikowski, Adriaan A. Voors, Gang Jia, Steven E. McNulty, Mahesh J. Patel, Lothar Roessig, Joerg Koglin, Christopher M. O’Connor

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> (<scp>Vericiguat</scp> Global Study in Subjects with <scp>HFrEF</scp>) trial

    Renal function and the effects of vericiguat in patients with worsening heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> (<scp>Vericiguat</scp> G... by Adriaan A. Voors, Hillary Mulder, Eugene B. Reyes, Martín Cowie, Johan Lassus, Adrian F. Hernandez, Justin A. Ezekowitz, Javed Butler, Christopher M. O’Connor, Joerg Koglin, Carolyn S.P. Lam, Burkert Pieske, Lothar Roessig, Piotr Ponikowski, Kevin J. Anstrom, Paul W. Armstrong

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial

    Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the <scp>VICTORIA</scp> trial by Piotr Ponikowski, Wendimagegn Alemayehu, Ali̇ Oto, M. Cecilia Bahit, Ebrahim Noori, Mahesh J. Patel, Javed Butler, Justin A. Ezekowitz, Adrian F. Hernandez, Carolyn S.P. Lam, Christopher M. O’Connor, Burkert Pieske, Lothar Roessig, Adriaan A. Voors, Cynthia M. Westerhout, Paul W. Armstrong

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: